Lin CC - Search Results

1

Immunotherapy in anaplastic thyroid cancer: Case series.

Shih SR, Chen KH, Lin KY, Yang PC, Chen KY, Wang CW, Chen CN, Lin CF, Lin CC. Shih SR, et al. Among authors: lin cf, lin ky, lin cc. J Formos Med Assoc. 2022 Jun;121(6):1167-1173. doi: 10.1016/j.jfma.2022.01.003. Epub 2022 Jan 12. J Formos Med Assoc. 2022. PMID: 35031200 Free article.

2

Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.

Lin ZZ, Hsu C, Chang YC, Yu CJ, Hsu CH, Lin CC, Cheng AL, Yang PC, Yang CH. Lin ZZ, et al. Among authors: lin cc. Lung Cancer. 2008 May;60(2):215-21. doi: 10.1016/j.lungcan.2007.10.002. Epub 2007 Nov 19. Lung Cancer. 2008. PMID: 18022277 Clinical Trial.

3

Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial.

Hsu C, Kuo SH, Hu FC, Cheng AL, Shih JY, Yu CJ, Lin CC, Huang TC, Yang PC, Yang CH. Hsu C, et al. Among authors: lin cc. Lung Cancer. 2008 Dec;62(3):334-43. doi: 10.1016/j.lungcan.2008.03.010. Epub 2008 May 2. Lung Cancer. 2008. PMID: 18450322 Clinical Trial.

4

Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer.

Lee JH, Lin YL, Hsu WH, Chen HY, Chang YC, Yu CJ, Shih JY, Lin CC, Chen KY, Ho CC, Laio WY, Yang PC, Yang JC. Lee JH, et al. Among authors: lin yl, lin cc. J Thorac Oncol. 2014 Sep;9(9):1385-92. doi: 10.1097/JTO.0000000000000238. J Thorac Oncol. 2014. PMID: 25057939 Free article.

5

A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement.

Chiang Y, Cheng JC, Huang CY, Tsai YC, Lin CC, Hsu CH, Cheng AL, Pu YS. Chiang Y, et al. Among authors: lin cc. J Formos Med Assoc. 2017 Sep;116(9):689-696. doi: 10.1016/j.jfma.2016.10.014. Epub 2016 Dec 26. J Formos Med Assoc. 2017. PMID: 28034491 Free article.

6

Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors.

Liao BC, Bai YY, Lee JH, Lin CC, Lin SY, Lee YF, Ho CC, Shih JY, Chang YC, Yu CJ, Chih-Hsin Yang J, Yang PC. Liao BC, et al. Among authors: lin sy, lin cc. J Formos Med Assoc. 2018 Apr;117(4):326-331. doi: 10.1016/j.jfma.2017.04.018. Epub 2017 May 9. J Formos Med Assoc. 2018. PMID: 28499641 Free article.

7

Using Ion Torrent sequencing to study genetic mutation profiles of fatal thyroid cancers.

Lu JY, Cheng WC, Chen KY, Lin CC, Chang CC, Kuo KT, Chen PL. Lu JY, et al. Among authors: lin cc. J Formos Med Assoc. 2018 Jun;117(6):488-496. doi: 10.1016/j.jfma.2017.05.007. Epub 2017 Jul 27. J Formos Med Assoc. 2018. PMID: 28757314 Free article.

8

Optimal usage of radium-223 in metastatic castration-resistant prostate cancer.

Cha TL, Wu TT, Vogelzang NJ, Huang CY, Huang SP, Lin CC, Ou YC, Pang ST, Shen DH, Wu WJ, Chang WY. Cha TL, et al. Among authors: lin cc. J Formos Med Assoc. 2017 Nov;116(11):825-836. doi: 10.1016/j.jfma.2017.04.005. Epub 2017 Oct 16. J Formos Med Assoc. 2017. PMID: 29046247 Free article. Review.

9

Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma.

Huang TC, Lin CC, Wu YC, Chia-Hsien Cheng J, Lee JM, Wang HP, Huang PM, Hsu FM, Yeh KH, Cheng AL, Tzen KY, Hsu CH. Huang TC, et al. Among authors: lin cc. J Formos Med Assoc. 2019 Jun;118(6):1024-1030. doi: 10.1016/j.jfma.2018.11.003. Epub 2018 Nov 28. J Formos Med Assoc. 2019. PMID: 30502100 Free article. Clinical Trial.

10

Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy.

Shih SR, Liao SL, Shih CW, Wei YH, Lu TX, Chou CH, Yen EY, Chang YC, Lin CC, Chi YC, Yang WS, Tsai FC. Shih SR, et al. Among authors: lin cc. Ocul Immunol Inflamm. 2021 Jan 2;29(1):193-202. doi: 10.1080/09273948.2019.1672196. Epub 2019 Oct 28. Ocul Immunol Inflamm. 2021. PMID: 31657648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,678 results

Search Page